Pharma and Biotech
Perspectives and best practices from the world of healthcare and life sciences.
Improving Patient Experience: A multidimensional measurement framework
A framework that can help us better measure patient experience, and allow organizations to continually learn, grow, and implement changes both small and large to improve patients’ experiences.
The Participation Problem: Addressing socioeconomic barriers in clinical trials
Genetics and socioeconomic factors can influence how a drug performs, and yet, a persistent gap remains between the people who need new treatments and those represented in the clinical trial data.
Hybrid co-creation in pharma and biotech
Bringing internal participants together for a hybrid co-creation creates shared intentions and speed to market.
Informed Consent in Healthcare: Adding to FDA Guidance
We share best practices in patient communication that may help comply with FDA guidance on informed consent, as well as practical tips.
HCP Communication Best Practices
HCP communications from the pharma industry need to be more focused, trustworthy, and multipurpose, to deliver value in the clinical setting.
Patient-centred communications in pharma and biotech
The Universal Patient Language (UPL) is an example of how a pharma company can create effective patient communications.
Treatment Decision-Making: A Framework
Commercial pharmaceutical teams should examine an array of factors that shape treatment decision-making to influence prescribing behaviour.
Once a month, we send out a newsletter of work-related ideas. Get our next edition delivered to your inbox.






